India, July 28 -- Concord Biotech announced the successful completion of the Russian GMP (Good Manufacturing Practice) inspection at our Active Pharmaceutical Ingredient (API) manufacturing facility located in Dholka, Gujarat. The inspection was conducted from July 22' 2025 to July 25' 2025.
Published by HT Digital Content Services with permission from Pivotal Sources....